| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,742 |
17,425 |
$1.35M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,230 |
8,227 |
$785K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,428 |
6,375 |
$248K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,606 |
1,594 |
$176K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,574 |
2,536 |
$129K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,354 |
2,343 |
$63K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,914 |
3,880 |
$58K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
341 |
341 |
$50K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
411 |
411 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
224 |
220 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
38 |
38 |
$2K |